Truist Financial’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,226
Closed -$109K 2740
2021
Q3
$109K Sell
10,226
-7,675
-43% -$81.8K ﹤0.01% 2599
2021
Q2
$278K Buy
17,901
+300
+2% +$4.66K ﹤0.01% 2381
2021
Q1
$285K Buy
17,601
+1,150
+7% +$18.6K ﹤0.01% 2296
2020
Q4
$348K Buy
16,451
+1,400
+9% +$29.6K ﹤0.01% 2042
2020
Q3
$223K Sell
15,051
-6,500
-30% -$96.3K ﹤0.01% 2177
2020
Q2
$317K Buy
21,551
+1,101
+5% +$16.2K ﹤0.01% 1895
2020
Q1
$240K Buy
20,450
+2,895
+16% +$34K ﹤0.01% 1981
2019
Q4
$412K Buy
+17,555
New +$412K ﹤0.01% 1963